BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30542727)

  • 1. Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma.
    Piao L; Yuan X; Zhuang M; Qiu X; Xu X; Kong R; Liu Z
    Oncol Rep; 2019 Jan; 41(1):325-332. PubMed ID: 30542727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins.
    Piao L; Nakakido M; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
    Oncotarget; 2016 Apr; 7(16):22846-56. PubMed ID: 26988914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.
    Zheng Y; Li B; Wang J; Xiong Y; Wang K; Qi Y; Sun H; Wu L; Yang L
    Clin Epigenetics; 2018 Oct; 10(1):129. PubMed ID: 30348215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
    Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.
    Liu Z; Piao L; Zhuang M; Qiu X; Xu X; Zhang D; Liu M; Ren D
    Oncol Rep; 2017 Nov; 38(5):2796-2802. PubMed ID: 28901481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
    Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
    Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
    Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
    Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.
    Askew EB; Bai S; Parris AB; Minges JT; Wilson EM
    Mol Cell Endocrinol; 2017 Mar; 443():42-51. PubMed ID: 28042025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of Variegation 3-9 Homolog 2, a Novel Binding Protein of Translationally Controlled Tumor Protein, Regulates Cancer Cell Proliferation.
    Kim AR; Sung JY; Rho SB; Kim YN; Yoon K
    Biomol Ther (Seoul); 2019 Mar; 27(2):231-239. PubMed ID: 30763986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and specificity of the human SUV39H2 protein lysine methyltransferase.
    Schuhmacher MK; Kudithipudi S; Kusevic D; Weirich S; Jeltsch A
    Biochim Biophys Acta; 2015 Jan; 1849(1):55-63. PubMed ID: 25459750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of TRAF4 expression suppresses osteosarcoma cell growth in vitro and in vivo.
    Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
    Int J Mol Med; 2014 Dec; 34(6):1655-60. PubMed ID: 25270078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone methyltransferase SUV39H2 regulates apoptosis and chemosensitivity in prostate cancer through AKT/FOXO signaling pathway.
    Sun D; Guo J; Liang W; Chen Y; Wei S; Li A; Wang L; Chen X
    Med Oncol; 2024 Jan; 41(2):44. PubMed ID: 38170382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated SUV39H2 attributes to the progression of nasopharyngeal carcinoma via regulation of NRIP1.
    Chao C; You J; Li H; Xue H; Tan X
    Biochem Biophys Res Commun; 2019 Mar; 510(2):290-295. PubMed ID: 30709585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
    Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
    Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
    Yin Z; Ding H; He E; Chen J; Li M
    Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation.
    Graziano AC; Cardile V; Avola R; Vicario N; Parenti C; Salvatorelli L; Magro G; Parenti R
    Oncotarget; 2017 Feb; 8(8):13917-13931. PubMed ID: 28107196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivirus-Mediated Knockdown of CTHRC1 Inhibits Osteosarcoma Cell Proliferation and Migration.
    Sang W; Zhu L; Ma J; Lu H; Wang C
    Cancer Biother Radiopharm; 2016 Apr; 31(3):91-8. PubMed ID: 27043295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z; Tang Y; Xing W; Dong W; Wang Z
    Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p.
    Zhou S; Yu L; Xiong M; Dai G
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1822-1832. PubMed ID: 29229388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger X-chromosomal protein (ZFX) promotes solid agar colony growth of osteosarcoma cells.
    Jiang R; Wang JC; Sun M; Zhang XY; Wu H
    Oncol Res; 2012; 20(12):565-70. PubMed ID: 24139414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.